Contracts › 75F40122C00192
75F40122C00192: Continuous Drug Substance Manufacturing From Biomass-Derived Building Blocks Baa Pmqwp #356.
Awarded to National Institute for Pharmaceutical Technology & Education Inc by Food and Drug Administration (FDA).
$3.0Mobligated
$3.0Mpotential value
28 September 2027current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75F40122C00192 |
|---|---|
| Awardee | National Institute for Pharmaceutical Technology & Education Inc |
| Awarding agency | Food and Drug Administration (FDA) |
| Awarding office | FDA OFFICE OF ACQ GRANT SVCS |
| NAICS | 541714 Research and Development in Biotechnology (Except Nanobiotechnology) |
| PSC | AN11 Health R&D Services; Health Care Services; Basic Research |
| Place of performance | MD |
| Offers received | 165 |
| Period of performance | 22 September 2022 to 28 September 2027 |
| Potential end | 28 September 2027 |
| Estimated recompete solicitation | ~Q2 2027 (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 03 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541714 contracts · All expiring contracts · USASpending record